SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

Ondas Holdings is a trending topic following the completion of a significant $1 billion offering to a single institutional investor at a premium, sparking widespread speculation about major strategic acquisitions and accelerated growth. The community is actively discussing upcoming investor events and the company's strong positioning for potential large government contracts in the rapidly expanding drone and counter-drone defense sector, fueling expectations for substantial future upside.

NANO Nuclear Energy, Inc. is a microreactor and nuclear technology company, which provides supply energy services. Its products in technical development are ZEUS, a solid core battery reactor, and ODIN, a low-pressure coolant reactor. The company is founded by Jiang Yu in February, 2022 and is headquartered in New York, NY.

Nano Nuclear Energy Inc.

Nano Nuclear Energy is actively discussed amidst a burgeoning nuclear sector, fueled by urgent AI data center power demands and favorable regulatory tailwinds. The company is trending following recent milestones, including a federal lawsuit dismissal, acquisition news, commencement of drilling for its KRONOS microreactor, and substantial institutional investment, though community debate on its valuation and dilution persists. Investors are closely watching its progress in developing microreactors to address the critical need for clean, reliable energy solutions.

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.

Travere Therapeutics Inc

Travere Therapeutics (TVTX) is trending due to intense investor speculation surrounding an upcoming FDA decision for its kidney therapy, FILSPARI, in Focal Segmental Glomerulosclerosis (FSGS). The community is sharply divided, with discussions fueled by notable insider selling and recent FDA requests for additional data, leading some to predict a regulatory setback while others aggressively buy the dip, anticipating a potential first-ever approval for FSGS.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Delta Air Lines is trending due to a strong quarterly earnings report that largely exceeded expectations, coupled with an optimistic outlook for the coming year. The community highlights the company's successful premium and loyalty strategy, driving robust revenue growth and reinforcing its leadership within the resilient travel sector.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Advanced Micro Devices (AMD) is a hot topic following a significant analyst upgrade, underscoring its pivotal role in the burgeoning AI and data center sectors. The community is engaged in a lively debate, weighing AMD's strong long-term AI growth potential with its advanced GPU and EPYC offerings against short-term price movements and competitive landscape considerations.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as its highly engaged community champions the "OG meme" narrative of Rage Comics, positioning it as a "foundational meme reset" for the current market cycle. This dedicated base actively builds an ecosystem with platforms like RageMaker and RageGames, expressing strong conviction and urging fellow enthusiasts to "Return to the Memes" and "Rage On" to reclaim leadership in the meme coin space.

Terrestrial Energy, Inc. is an advanced nuclear technology company focused on next-generation nuclear energy systems. The company is developing the Integral Molten Salt Reactor (IMSR), an innovative type of Generation IV molten salt reactor designed to produce reliable, low-carbon heat and electricity at competitive costs. The company is headquartered in Charlotte, NC.

Terrestrial Energy Inc.

Terrestrial Energy (IMSR) is experiencing heightened investor interest following its recent agreement with the U.S. Department of Energy for Project TETRA, an initiative to construct and operate a pilot nuclear reactor. The community is actively discussing IMSR's advanced molten salt reactor technology, often comparing it favorably to other sector leaders and highlighting its potential to meet the surging demand for stable, clean energy from industries like AI and data centers.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas (BOIL) is heavily discussed amid a significant sell-off in natural gas prices, primarily due to warmer-than-anticipated winter weather forecasts reducing heating demand and contributing to an oversupplied market. The community is sharply divided, with many lamenting substantial losses and alleging market manipulation, while a determined subset anticipates a colder shift and potential short squeeze despite the ETF's inherent decay.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is trending due to compelling interim Phase 1 data for its obesity treatment, WVE-007, which showcases visceral fat reduction and muscle preservation without the typical GLP-1 side effects. This promising differentiation is igniting community discussions about a potential acquisition or bidding war from major pharmaceutical players eager for next-generation assets in the intensely competitive obesity market. Analysts are increasingly raising price targets, despite some market participants remaining cautious about the early-stage nature of the data and recent share offerings.

Dash (DASH) is digital cash designed to offer financial freedom to everyone. Payments are instant, easy and secure, with near-zero fees. Built to support real life use cases, Dash is the leading decentralized payment solution. Users can purchase goods at thousands of merchants and trade it at major exchanges and brokers around the globe. Since its creation in 2014, Dash has demonstrated leadership in innovation and pioneered groundbreaking features such as: -Two-tier network with incentivized nodes and decentralized project governance (Masternodes) -Instantly settled payments (InstantSend) -Instantly immutable blockchain (ChainLocks) -Optional privacy (PrivateSend)

Dash

Dash is trending as community sentiment anticipates a significant rally, drawing comparisons to Zcash's recent performance within the privacy token sector. Investors are discussing upcoming regulatory clarity and increasing institutional interest in privacy tokens, highlighting Dash's scarce supply and utility. This positions Dash for potential broader adoption in the evolving digital asset landscape, with many anticipating a broader altcoin market upturn.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Immunic (NASDAQ:IMUX) Shares Up 9.3% - Should You Buy?

Immunic (NASDAQ:IMUX) Shares Up 9.3% - Here's What Happened...

Immunic, Inc. (NASDAQ:IMUX) Given Average Rating of "Buy" by Analysts

Immunic, Inc. (NASDAQ:IMUX - Get Free Report) has been assigned a consensus recommendation of "Buy" from the eight research firms that are presently covering the company, MarketBeat reports. One...

Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December

Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December PR Newswire NEW YORK...

Analysts Offer Predictions for Immunic FY2025 Earnings

Immunic, Inc. (NASDAQ:IMUX - Free Report) - Investment analysts at Chardan Capital issued their FY2025 earnings per share estimates for Immunic in a research note issued to investors on Wednesday...

Equities Analysts Issue Forecasts for Immunic Q1 Earnings

Immunic, Inc. (NASDAQ:IMUX - Free Report) - Investment analysts at Brookline Capital Management issued their Q1 2026 earnings estimates for shares of Immunic in a research report issued to clients...

HC Wainwright Cuts Immunic (NASDAQ:IMUX) Price Target to $8.00

HC Wainwright lowered their target price on shares of Immunic from $10.00 to $8.00 and set a "buy" rating for the company in a research note on Friday...

Immunic (NASDAQ:IMUX) Issues Quarterly Earnings Results, Beats Expectations By $0.05 EPS

Immunic (NASDAQ:IMUX - Get Free Report) released its quarterly earnings results on Thursday. The company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.18) by $0.05...

D. Boral Capital Cuts Immunic (NASDAQ:IMUX) Price Target to $8.00

D. Boral Capital reduced their target price on Immunic from $10.00 to $8.00 and set a "buy" rating for the company in a report on Thursday...

Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update PR Newswire NEW YORK...

Q3 Earnings Forecast for Immunic Issued By Roth Capital

Immunic, Inc. (NASDAQ:IMUX - Free Report) - Equities researchers at Roth Capital issued their Q3 2025 EPS estimates for Immunic in a research report issued on Friday, November 7th. Roth Capital...

Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on multiple sclerosis, celiac disease and other neurologic and gastrointestinal disorders. The firm's products include IMU-838, IMU-856, and IMU-381. The company was founded in 2016 and is headquartered in New York, NY.

Immunic Inc

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

IMUX
Immunic Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest IMUX News

IMUXImmunic Inc